Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Litzow MD

Mark R. Litzow MD

Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota

Dr. Litzow is Professor of Medicine in the Division of Hematology at Mayo Clinic. He was the Director of the BMT Program at Mayo from 1992 to 2008 and continues to remain active in the BMT program. He was the Director of the Myeloid Disease Oriented Group in the Division of Hematology from 2002 to 2016. He was appointed chair of the Leukemia Committee of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) in September 2013 after having served as co-chair of the committee since 2001. He is a past co-chair of the Acute Leukemia Working Committee of the CIBMTR.  He became board certified in Hospice and Palliative Medicine in 2013 and is a member of the Palliative Medicine Program at Mayo Clinic in Rochester.

His research interests include clinical trials for acute and chronic leukemia including blood and marrow transplantation and supportive care of blood and marrow transplant patients.  He is the author of over 600 manuscripts and multiple book chapters.

Disclosures

Dr. Litzow receives research funding from and serves on a speaker’s bureau for Amgen.